Adebrelimab Plus Full-course Neoadjuvant Therapy for Resectable Locally Advanced ESCC (Phase 2)

Name: Adebrelimab Plus Full-course Neoadjuvant Therapy for Resectable Locally Advanced ESCC (Phase 2)
License: Public Domain

Tianjin Medical University Cancer Institute and Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

escc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 390918
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.